16805745|t|Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
16805745|a|Cholinesterase inhibition in patients with Alzheimer's disease (AD) may affect heart rate, sometimes inducing bradycardia. Additional cardiac safety considerations apply in patients with dementia with Lewy bodies (DLB) and Parkinson's disease (PDD), in whom cardiovascular autonomic nervous system dysfunction is common. We conducted a review of the safety data available for rivastigmine in these two conditions. A modest reduction in the mean heart rate of 1.5-2 bpm was seen. No clinically meaningful treatment differences in bradycardia or ECG abnormalities were apparent. Compared with placebo, rivastigmine appeared to be associated with fewer vascular disorder adverse events (AEs) (p = 0.002) and fewer AEs of syncope (p = 0.018) in PDD patients (n = 541). A smaller randomised, placebo-controlled study of rivastigmine in DLB (n = 120) showed similar findings. Rivastigmine appears to have a favourable cardiac safety profile in PDD and DLB patients.
16805745	18	30	rivastigmine	Chemical	MESH:D000068836
16805745	34	43	Lewy body	Disease	MESH:D020961
16805745	48	77	Parkinson's disease dementias	Disease	MESH:D010300
16805745	79	93	Cholinesterase	Gene	590
16805745	108	116	patients	Species	9606
16805745	122	141	Alzheimer's disease	Disease	MESH:D000544
16805745	143	145	AD	Disease	MESH:D000544
16805745	189	200	bradycardia	Disease	MESH:D001919
16805745	252	260	patients	Species	9606
16805745	266	291	dementia with Lewy bodies	Disease	MESH:D020961
16805745	293	296	DLB	Disease	MESH:D020961
16805745	302	321	Parkinson's disease	Disease	MESH:D010300
16805745	323	326	PDD	Disease	MESH:D003966
16805745	337	388	cardiovascular autonomic nervous system dysfunction	Disease	MESH:D001342
16805745	455	467	rivastigmine	Chemical	MESH:D000068836
16805745	608	619	bradycardia	Disease	MESH:D001919
16805745	623	640	ECG abnormalities	Disease	MESH:D053840
16805745	679	691	rivastigmine	Chemical	MESH:D000068836
16805745	729	746	vascular disorder	Disease	MESH:D002561
16805745	797	804	syncope	Disease	MESH:D013575
16805745	820	823	PDD	Disease	MESH:D003966
16805745	824	832	patients	Species	9606
16805745	894	906	rivastigmine	Chemical	MESH:D000068836
16805745	910	913	DLB	Disease	MESH:D020961
16805745	949	961	Rivastigmine	Chemical	MESH:D000068836
16805745	1017	1020	PDD	Disease	MESH:D003966
16805745	1025	1028	DLB	Disease	MESH:D020961
16805745	1029	1037	patients	Species	9606
16805745	Negative_Correlation	MESH:D000068836	MESH:D010300
16805745	Negative_Correlation	MESH:D000544	590
16805745	Negative_Correlation	MESH:D000068836	MESH:D013575
16805745	Negative_Correlation	MESH:D000068836	MESH:D002561
16805745	Negative_Correlation	MESH:D000068836	MESH:D003966
16805745	Negative_Correlation	MESH:D000068836	MESH:D020961
16805745	Association	MESH:D001919	590

